Advertisement

Updated April 7th, 2021 at 09:09 IST

European Union's Medical Regulator to make statement on AstraZeneca

A top official with the European medicines agency said that there is a "causal link" between the AstraZeneca vaccine and rare blood clots.

Reported by: Apoorva Kaul
(Image Credits: ANI/AP)
AstraZeneca | Image:self
Advertisement

European medicines agency top official said that there is a causal link between the AstraZeneca vaccine and rare blood clots. he said that it's unclear what the connection is but the benefits of taking the vaccine still outweigh the risks of getting covid-19. European Union's Medical Regulator is going to make a definitive statement on the Astrazeneca blood clot topic.

EMR to make statement on AstraZeneca 

Marco cavalry, head of health threats and vaccines strategy at the Amsterdam based energy agency told rooms 1 l Messaggero newspaper that the European medicines regulator is preparing to make a more definitive statement on the topic this week. The EMA press office said that the evaluation of the vaccine has not concluded. They are currently reviewing the vaccine and as soon as the review is concluded, a press conference will be organised on April 8 or April 9.

Cavaleri said that based on the evidence, there is an association between AstraZeneca vaccines and rare blood clots. The pharmaceutical company and Oxford University which developed the vaccine announced they were pausing the trial of their jabs in children. The World Health Organization said that its experts were also evaluating the link between the AstraZeneca vaccine and rare blood clots.

Earlier last month, several countries in the European Union had temporarily suspended the use of AstraZeneca’s vaccine over reports of blood clots in recipients. The European Medicines Agency (EMA) launched an investigation into the reports of blood clots in people who had been given AstraZeneca’s COVID-19 vaccine. On March 18, EMA concluded that there was no increase in the overall risk of blood clots in recipients of AstraZeneca’s vaccine, reaffirming its safety and efficacy. 

The British medicines regulator MHRA also backed the AstraZeneca vaccine while confirming at least 30 cases of rare blood clots amongst UK recipients. MHRA categorically stated that the risks associated with the vaccine are worth the protection that it provides against the viral disease, which is continuing to rage havoc in the country. Germany and the Netherlands have said they will suspend the use of the AstraZeneca vaccine for use in people aged 60 or above. 

(Image Credits: ANI/AP)

(Inputs from The Associated Press)

Advertisement

Published April 7th, 2021 at 09:09 IST

Your Voice. Now Direct.

Send us your views, we’ll publish them. This section is moderated.

Advertisement
Advertisement

Trending Quicks

BCAS started the continuous exercise of monitoring the time of arrival of baggage at belts of six major airports in January 2024.
a few seconds ago
Bribery
2 minutes ago
Kashmiri Lakes
4 minutes ago
Bill Gates and PM Modi to Discuss ‘From AI to Digital Payments’
11 minutes ago
Elon Musk X lawsuit
12 minutes ago
Government bonds
12 minutes ago
Beans
14 minutes ago
Supriya Shrinate clarification
20 minutes ago
vk saxena
24 minutes ago
Advertisement
Advertisement
Advertisement
Whatsapp logo